Funding search · EIN 134171637 · New York, NY
Fund for Ophthalmic Knowledge
A grantmaking public charity (files IRS Form 990, Schedule I). Charities like this often run real grant programs with application cycles.
- 3
- grants reported
- $416,004
- total given
- 2022–2024
- filing years
- $161,184
- median grant
Based on grants this organization reported to the IRS for tax years 2022–2024. This is what they filed, not a complete record of their giving, and recent years may be incomplete because filings lag.
Funder website ↗Full IRS filings ↗How this is builtReport an error
Funding pattern
What this funder pays for, at what size, and how to position adjacent work. Read from their filings, with every number checked against the record.
Sign in to analyze this funder’s giving pattern. Free in early access.
Grant history
All 3 reported grants, largest first.
- $198,692
Memorial Sloan Kettering Cancer Center · New York, NY · 2023
Supported research on eye cancer performed at mskcc: studies on cell free dna in plasma of retinoblastoma patients, studies of choroidal invasion in retinoblastoma, studies of the use of intrarterial chemotherapy in his… read allSupported research on eye cancer performed at mskcc: studies on cell free dna in plasma of retinoblastoma patients, studies of choroidal invasion in retinoblastoma, studies of the use of intrarterial chemotherapy in histiocytosis, studies on efficacy and toxicity of intravitreal topotecan for eye cancer. less
- $161,184
Memorial Sloan Kettering Cancer Center · New York, NY · 2022
Supported research on eye cancer performed at mskcc: studies on cell free dna in plasma of retinoblastoma patients, studies of choroidal invasion in retinoblastoma, studies of the use of intrarterial chemotherapy in his… read allSupported research on eye cancer performed at mskcc: studies on cell free dna in plasma of retinoblastoma patients, studies of choroidal invasion in retinoblastoma, studies of the use of intrarterial chemotherapy in histiocytosis, studies on efficacy and toxicity of intravitreal topotecan for eye cancer. less
- $56,128
Memorial Sloan Kettering Cancer Center · New York, NY · 2024
Supported research on eye cancer performed at mskcc: studies on cell free dna in plasma of retinoblastoma patients, studies of choroidal invasion in retinoblastoma, studies of the use of intrarterial chemotherapy in his… read allSupported research on eye cancer performed at mskcc: studies on cell free dna in plasma of retinoblastoma patients, studies of choroidal invasion in retinoblastoma, studies of the use of intrarterial chemotherapy in histiocytosis, studies on efficacy and toxicity of intravitreal topotecan for eye cancer. less
Grants already paid are the record; PaperOrbit reads your paper and finds the funders whose record matches it — then explains why.
Search funders like this oneSource: IRS Form 990, Schedule I, as filed by this organization. These are grants already paid. Grants paid directly to individuals are reported to the IRS only as totals, so they do not appear as named lines here.